European Society of Cardiology (ESC) - Articles and news items

TECOS analysis adds heart failure data for sitagliptin

Industry news / 2 September 2015 / Victoria White

New TECOS study findings have shown that patients with type-2 diabetes can safely take sitagliptin without an increased risk of cardiovascular complications…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+